P

Poolbeg Pharma PLC
LSE:POLB

Watchlist Manager
Poolbeg Pharma PLC
LSE:POLB
Watchlist
Price: 7.75 GBX 1.97% Market Closed
Market Cap: 38.8m GBX
Have any thoughts about
Poolbeg Pharma PLC?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-5.6
Current
0
Median
13.3
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-5.6
=
Enterprise Value
28.7m GBX
/
EBITDA
-5.1m GBP
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-4.6
2-Years Forward
EV/EBITDA
-4.6
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More